• 1
    Crippa JA, Derenusson GN, Ferrari TB et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report. J. Psychopharmacol. 2011; 25: 121130.
  • 2
    Crippa JA, Zuardi AW, Martin-Santos R et al. Cannabis and anxiety: A critical review of the evidence. Hum. Psychopharmacol. 2009; 24: 515523.
  • 3
    Fusar-Poli P, Crippa JA, Bhattacharyya S et al. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch. Gen. Psychiatry 2009; 66: 95105.
  • 4
    Fusar-Poli P, Allen P, Bhattacharyya S et al. Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol. Int. J. Neuropsychopharmacol. 2010; 13: 421432.
  • 5
    Bhattacharyya S, Morrison PD, Fusar-Poli P et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 2010; 35: 764774.
  • 6
    Bhattacharyya S, Fusar-Poli P, Borgwardt S et al. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: A neural basis for the effects of Cannabis sativa on learning and psychosis. Arch. Gen. Psychiatry 2009; 66: 442451.
  • 7
    Bhattacharyya S, Crippa JA, Allen P et al. Induction of psychosis by delta 9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch. Gen. Psychiatry 2012; 69: 2736.
  • 8
    Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yucel M. Structural MRI findings in long-term cannabis users: What do we know? Subst. Use Misuse 2010; 45: 17871808.
  • 9
    Rapp C, Bugra H, Riecher-Rossler A, Tamagni C, Borgwardt S. Effects of cannabis use on human brain structure in psychosis: A systematic review combining in vivo structural neuroimaging and post mortem studies. Curr. Pharm. Des. 2012; 18: 50705080.
  • 10
    Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical maps of psychosis onset: Voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr. Bull. 2012; 38: 12971307.
  • 11
    Hermann D, Schneider M. Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: A critical review. Curr. Pharm. Des. 2012; 18: 48974905.
  • 12
    Jager G, Ramsey NF. Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: An overview of animal and human research. Curr Drug Abuse Rev 2008; 1: 114123.
  • 13
    Martin-Santos R, Fagundo AB, Crippa JA et al. Neuroimaging in cannabis use: A systematic review of the literature. Psychol. Med. 2010; 40: 383398.
  • 14
    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339: b2535.
  • 15
    Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. QUOROM Group. Br. J. Surg. 2000; 87: 14481454.
  • 16
    Courchesne E, Chisum HJ, Townsend J et al. Normal brain development and aging: Quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 2000; 216: 672682.
  • 17
    Borenstein MHL, Higgins J, Rothstein H. Comprehensive Meta-Analysis Version 2. Biostat, Englewood, NJ, 2005.
  • 18
    Hedges L, Holkin I. Statistical Methods for Meta-Analysis. Academic Press, New York, 1985.
  • 19
    Fleiss JL. The statistical basis of meta-analysis. Stat. Methods Med. Res. 1993; 2: 121145.
  • 20
    Cooper H, Hedges L, Valentine J. Handbook of Research Synthesis and Meta-Analysis. Russell Sage Foundation, New York, 2009.
  • 21
    Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: A meta-analysis. JAMA 2010; 303: 19611969.
  • 22
    Lipsey M, Wilson D. Practical Meta-Analysis. Sage Publications, Thousand Oaks, CA, 2000.
  • 23
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629634.
  • 24
    Orwin R. A fail-safe N for effect size in meta-analysis. J Edu Stat 1983; 8: 157159.
  • 25
    Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455463.
  • 26
    Batalla A, Soriano-Mas C, Lopez-Sola M et al. Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users. Addict. Biol. 2013. doi: 10.1111/adb.12027
  • 27
    Schacht JP, Hutchison KE, Filbey FM. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology 2012; 37: 23682376.
  • 28
    Zalesky A, Solowij N, Yucel M et al. Effect of long-term cannabis use on axonal fibre connectivity. Brain 2012; 135: 22452255.
  • 29
    Ashtari M, Avants B, Cyckowski L et al. Medial temporal structures and memory functions in adolescents with heavy cannabis use. J. Psychiatr. Res. 2011; 45: 10551066.
  • 30
    Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 2012; 59: 38453851.
  • 31
    Lopez-Larson MP, Bogorodzki P, Rogowska J et al. Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav. Brain Res. 2011; 220: 164172.
  • 32
    McQueeny T, Padula CB, Price J, Medina KL, Logan P, Tapert SF. Gender effects on amygdala morphometry in adolescent marijuana users. Behav. Brain Res. 2011; 224: 128134.
  • 33
    Mata I, Perez-Iglesias R, Roiz-Santianez R et al. Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use. Brain Res. 2010; 1317: 297304.
  • 34
    Yucel M, Solowij N, Respondek C et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch. Gen. Psychiatry 2008; 65: 694701.
  • 35
    Medina KL, Nagel BJ, Park A, McQueeny T, Tapert SF. Depressive symptoms in adolescents: Associations with white matter volume and marijuana use. J. Child Psychol. Psychiatry 2007; 48: 592600.
  • 36
    Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol. Teratol. 2007; 29: 141152.
  • 37
    Delisi LE, Bertisch HC, Szulc KU et al. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm. Reduct. J. 2006; 3: 1722.
  • 38
    Tzilos GK, Cintron CB, Wood JB et al. Lack of hippocampal volume change in long-term heavy cannabis users. Am. J. Addict. 2005; 14: 6472.
  • 39
    Block RI, O'Leary DS, Ehrhardt JC et al. Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 2000; 11: 491496.
  • 40
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002; 21: 15391558.
  • 41
    Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J. Altered parahippocampal functioning in cannabis users is related to the frequency of use. Psychopharmacology (Berl) 2010; 209: 361374.
  • 42
    Benes FM, Turtle M, Khan Y, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch. Gen. Psychiatry 1994; 51: 477484.
  • 43
    Sturman DA, Moghaddam B. The neurobiology of adolescence: Changes in brain architecture, functional dynamics, and behavioral tendencies. Neurosci. Biobehav. Rev. 2011; 35: 17041712.
  • 44
    Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 2005; 168: 299325.
  • 45
    Chan GC, Hinds TR, Impey S, Storm DR. Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J. Neurosci. 1998; 18: 53225332.
  • 46
    Hoffman AF, Lupica CR. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci. 2000; 20: 24702479.
  • 47
    Kim D, Thayer SA. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J. Neurosci. 2001; 21: RC146.
  • 48
    Carlson G, Wang Y, Alger BE. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 2002; 5: 723724.
  • 49
    Solowij N, Battisti R. The chronic effects of cannabis on memory in humans: A review. Curr. Drug Abuse Rev. 2008; 1: 8198.
  • 50
    Squire LR, Stark CE, Clark RE. The medial temporal lobe. Annu. Rev. Neurosci. 2004; 27: 279306.
  • 51
    Wagner D, Becker B, Gouzoulis-Mayfrank E, Daumann J. Interactions between specific parameters of cannabis use and verbal memory. Prog. Neuropsychopharmacol Biol. Psychiatry 2010; 34: 871876.
  • 52
    Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch. Gen. Psychiatry 2001; 58: 909915.
  • 53
    Dhikav V, Anand K. Potential predictors of hippocampal atrophy in Alzheimer's disease. Drugs Aging 2011; 28: 111.
  • 54
    Potter DJ, Clark P, Brown MB. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: Implications for psychoactivity and pharmacology. J. Forensic Sci. 2008; 53: 9094.
  • 55
    Demirakca T, Sartorius A, Ende G et al. Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol. Drug Alcohol Depend. 2011; 114: 242245.
  • 56
    Cascini F, Aiello C, Di Tanna G. Increasing delta-9-tetrahydrocannabinol (Delta-9-THC) content in herbal cannabis over time: Systematic review and meta-analysis. Curr Drug Abuse Rev 2012; 5: 3240.
  • 57
    Cheetham A, Allen NB, Whittle S, Simmons JG, Yucel M, Lubman DI. Orbitofrontal volumes in early adolescence predict initiation of cannabis use: A 4-year longitudinal and prospective study. Biol. Psychiatry 2012; 71: 684692.